Litigation Details for Indivior Inc. v. Mylan Technologies Inc. (D. Del. 2015)
✉ Email this page to a colleague
Indivior Inc. v. Mylan Technologies Inc. (D. Del. 2015)
Docket | ⤷ Sign Up | Date Filed | 2015-11-04 |
Court | District Court, D. Delaware | Date Terminated | 2019-09-05 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 8,017,150; 8,475,832; 8,603,514 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Indivior Inc. v. Mylan Technologies Inc.
Details for Indivior Inc. v. Mylan Technologies Inc. (D. Del. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2015-11-04 | 1 | Complaint | United States Patent Nos. 8,475,832 (“the ʼ832 patent”), 8,017,150 (“the ʼ150 patent”), and 8,603,514…ʼ150 patent, and Plaintiff Indivior is an exclusive licensee of the ʼ150 patent. The ʼ150 patent, entitled…ʼ514 patent, and Plaintiff Indivior is an exclusive licensee of the ʼ514 patent. The ʼ514 patent, entitled…is an action for patent infringement arising under the Food and Drug Laws and Patent Laws of the United…8,603,514 (“the ’514 patent”) (collectively, “the patents-in-suit”). Case 1:15-cv-01016-RGA Document 1 Filed | External link to document |
2017-05-30 | 147 | Notice of Service | Regarding Alvogen's Infringement of U.S. Patent Number 8,017,150; and 5. Expert Report of Dr. Robert K. …'homme Regarding Alvogen's Infringement of U.S. Patent Number 8,603,514; 3. Expert Report of Martyn C.… Ph.D. Regarding Alvogen's Infringement of U.S. Patent No. 8,603,514; 4. Expert Report of Dr. Robert K…'homme Regarding Alvogen's Infringement of U.S. Patent Number 8,900,497. filed by Indivior Inc., Indivior…November 2015 8 May 2018 1:15-cv-01016 830 Patent None District Court, D. Delaware | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |